[使用新型荧光试剂荧光法测定生物材料中的西帕胺] - Suppr | 超能文献

[Fluorimetric determination of xipamide in biological materials using a new fluorescence reagent].

作者信息

Sobel M, Mutschler E

出版信息

J Chromatogr. 1980 Jul 11;183(1):124-30.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Fluorimetric determination of xipamide in biological materials using a new fluorescence reagent].[使用新型荧光试剂荧光法测定生物材料中的西帕胺]

J Chromatogr. 1980 Jul 11;183(1):124-30.

2

High-performance liquid chromatographic determination of xipamide in human plasma.高效液相色谱法测定人血浆中的希帕胺

Analyst. 1988 Feb;113(2):229-31. doi: 10.1039/an9881300229.

3

Rapid determination of xipamide in human plasma and urine by high-performance liquid chromatography.高效液相色谱法快速测定人血浆和尿液中的西帕胺

J Chromatogr. 1990 Nov 30;533:275-81. doi: 10.1016/s0378-4347(00)82214-8.

4

Determination of Xipamide metabolite in human urine by high-performance liquid chromatography/diode-array detection, high-performance liquid chromatography/electrospray ionization mass spectrometry and gas chromatography/mass spectrometry.采用高效液相色谱/二极管阵列检测法、高效液相色谱/电喷雾电离质谱法和气相色谱/质谱法测定人尿中希帕胺代谢物。

Rapid Commun Mass Spectrom. 2004;18(20):2505-12. doi: 10.1002/rcm.1636.

5

[Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].[氯磺丙脲的作用机制及其作为“低效能利尿剂”的分类。在健康志愿者以及肾脏和肝脏疾病患者中的药效学-药代动力学研究]

Arzneimittelforschung. 2005;55(1):1-14. doi: 10.1055/s-0031-1296819.

6

[Pharmacokinetics of xipamide and triamterene in healthy probands].

Arzneimittelforschung. 1982;32(11):1482-5.

7

[Determination of N-acetyl-beta-D-glucosaminidase activity of the urine using colorimetric and fluorimetric assay].[采用比色法和荧光法测定尿液中N-乙酰-β-D-氨基葡萄糖苷酶活性]

Z Med Lab Diagn. 1988;29(5):254-62.

8

[Protein binding of xipamide (4-chloro-5-sulfamoyl-2',6'-salicyloxylidide].[氯噻嗪（4-氯-5-磺酰胺基-2',6'-水杨酰替苯胺）的蛋白质结合]

Arzneimittelforschung. 1975 Feb;25(2):258-9.

9

Studies covering combined treatments with xipamide. Results of a long-term antihypertensive treatment.

Int J Clin Pharmacol Biopharm. 1977 Jun;15(6):260-6.

10

Bioavailability study of triamterene and xipamide using urinary pharmacokinetic data following single oral dose of each drug or their combination.采用单次口服给药后尿药动力学数据研究氨苯蝶啶和噻嗪酰胺的生物利用度及其联合用药。

J Pharm Biomed Anal. 2012 Mar 5;61:78-85. doi: 10.1016/j.jpba.2011.11.032. Epub 2011 Dec 6.

引用本文的文献

1

Pharmacodynamics and pharmacokinetics of xipamide in patients with normal and impaired kidney function.氯噻嗪在肾功能正常和受损患者中的药效学和药代动力学。

Eur J Clin Pharmacol. 1984;26(4):513-20. doi: 10.1007/BF00542150.

2

Xipamide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.氯噻嗪。对其药效学、药代动力学特性及治疗效果的综述。

Drugs. 1985 Oct;30(4):313-32. doi: 10.2165/00003495-198530040-00002.

3

Clinical pharmacokinetics of some newer diuretics.一些新型利尿剂的临床药代动力学

Clin Pharmacokinet. 1987 Oct;13(4):254-66. doi: 10.2165/00003088-198713040-00003.